River 3 Renal Funding: $40M Raised, Series A (2021)
River 3 Renal is based in New York. It has raised $40M in total funding. Latest round: Series A.
River 3 Renal funding overview
River 3 Renal is based in New York. River 3 Renal has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2021. The round record for River 3 Renal runs through 2021; nothing later has been disclosed. Investors on record include SR One, Bain Capital Life Sciences, HBM Healthcare Investments, Pureos Bioventures. 4 distinct backers are named across the disclosed rounds.
River 3 Renal at a glance
Total raised
$40M
Latest round
Series A
Latest round date
January 2021
Headquarters
New York
Notable investors
SR One, Bain Capital Life Sciences, HBM Healthcare Investments, Pureos Bioventures
Frequently asked about River 3 Renal funding
How much has River 3 Renal raised?
River 3 Renal has raised $40M in total disclosed funding across the rounds on record.
Who has invested in River 3 Renal?
SR One, Bain Capital Life Sciences, HBM Healthcare Investments, Pureos Bioventures are named among the investors backing River 3 Renal.
What was the latest River 3 Renal funding round?
The most recent disclosed round is a Series A, announced in January 2021.
Where is River 3 Renal based?
River 3 Renal is based in New York.
When did River 3 Renal last raise?
The last disclosed River 3 Renal round closed in January 2021 at Series A.
River 3 Renal totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in New York below to benchmark round size and investor mix.
